These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1847389)
1. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. Schoenfeld HJ; Poeschl B; Frey JR; Loetscher H; Hunziker W; Lustig A; Zulauf M J Biol Chem; 1991 Feb; 266(6):3863-9. PubMed ID: 1847389 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. Andrews JS; Berger AE; Ware CF J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453 [TBL] [Abstract][Full Text] [Related]
3. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies. Jin H; Uddin MS; Huang YL; Teo WK J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497 [TBL] [Abstract][Full Text] [Related]
4. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response. Aggarwal BB; Eessalu TE J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858 [TBL] [Abstract][Full Text] [Related]
5. [Preparation of lymphotoxin and properties of it]. Lebedev LR; Pustoshilova NM; Sinichkina SA; Andreeva IS Prikl Biokhim Mikrobiol; 1998; 34(1):120-6. PubMed ID: 9566293 [TBL] [Abstract][Full Text] [Related]
6. [Recombinant human lymphotoxin: synthesis in Escherichia coli cells, purification, and certain properties]. Denisov AA; Torskiĭ SP; Nikolaeva OG; Volozhantseva IIa Biokhimiia; 1995 Sep; 60(9):1403-10. PubMed ID: 8562649 [TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. Buck C; Digel W; Schöniger W; Stefanic M; Ragnavachar A; Heimpel H; Porzsolt F Leukemia; 1990 Jun; 4(6):431-4. PubMed ID: 2162999 [TBL] [Abstract][Full Text] [Related]
8. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines. Beran M; Andersson BS; Kelleher P; Whalen K; McCredie K; Gutterman J Blood; 1987 Mar; 69(3):721-6. PubMed ID: 3028534 [TBL] [Abstract][Full Text] [Related]
9. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744 [TBL] [Abstract][Full Text] [Related]
10. Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins. Aggarwal BB; Traquina PR; Eessalu TE J Biol Chem; 1986 Oct; 261(29):13652-6. PubMed ID: 3020039 [TBL] [Abstract][Full Text] [Related]
11. A tumor necrosis factor binding protein is present in human biological fluids. Peetre C; Thysell H; Grubb A; Olsson I Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215 [TBL] [Abstract][Full Text] [Related]
12. Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937. Stauber GB; Aggarwal BB J Biol Chem; 1989 Feb; 264(6):3573-6. PubMed ID: 2536752 [TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a relationship between the T-lymphocyte derived differentiation inducing factor (DIF) and lymphotoxin: a common receptor system for DIF, lymphotoxin and tumor necrosis factor downregulated by phorbol diesters. Gullberg U; Lantz M; Nilsson E; Peetre C; Adolf G; Olsson I Eur J Haematol; 1987 Sep; 39(3):241-51. PubMed ID: 2824237 [TBL] [Abstract][Full Text] [Related]
15. Effect of phorbol esters on down-regulation and redistribution of cell surface receptors for tumor necrosis factor-alpha. Aggarwal BB; Eessalu TE J Biol Chem; 1987 Dec; 262(34):16450-5. PubMed ID: 2824494 [TBL] [Abstract][Full Text] [Related]
16. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity. Nissen-Meyer J; Austgulen R; Espevik T Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918 [TBL] [Abstract][Full Text] [Related]
17. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Rutka JT; Giblin JR; Berens ME; Bar-Shiva E; Tokuda K; McCulloch JR; Rosenblum ML; Eessalu TE; Aggarwal BB; Bodell WJ Int J Cancer; 1988 Apr; 41(4):573-82. PubMed ID: 2833452 [TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant human lymphotoxin (tumor necrosis factor-beta) produced by a mammalian cell line. Hains JM; Aggarwal BB Arch Biochem Biophys; 1989 Nov; 274(2):417-25. PubMed ID: 2802619 [TBL] [Abstract][Full Text] [Related]
19. A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1. Aso H; Yoshite O; Tomioka Y; Rose MT; Mizugaki M Microbiol Immunol; 1999; 43(1):53-9. PubMed ID: 10100747 [TBL] [Abstract][Full Text] [Related]